Literature DB >> 28449634

Neuropsychiatric Associations With Gender, Illness Duration, Work Disability, and Motor Subtype in a U.S. Functional Neurological Disorders Clinic Population.

Nassim Matin1, Sigrid S Young1, Benjamin Williams1, W Curt LaFrance1, Julie N King1, David Caplan1, Zeina Chemali1, Jeffery B Weilburg1, Bradford C Dickerson1, David L Perez1.   

Abstract

The assessment of functional neurological disorders (FND) requires an interdisciplinary approach. The authors retrospectively reviewed charts for 100 outpatients with FND and used univariate and regression analyses to investigate neuropsychiatric associations with gender, illness duration, and work disability; secondary analyses evaluated for differences across motor FND subtypes. Men reported higher rates of cognitive complaints and functional weakness, whereas women endorsed increased past physical/sexual trauma. Number of self-reported medication allergies/sensitivities positively correlated with illness duration. Individuals with functional weakness compared with other motor FND subtypes exhibited lower rates of past psychiatric hospitalization and head trauma. This study supports the feasibility of integrating FND research.

Entities:  

Keywords:  Conversion Disorder; Functional Movement Disorders; Functional Neurological Disorder; Functional Weakness; Psychogenic Nonepileptic Seizures

Mesh:

Year:  2017        PMID: 28449634     DOI: 10.1176/appi.neuropsych.16110302

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  7 in total

1.  Cortical thickness alterations linked to somatoform and psychological dissociation in functional neurological disorders.

Authors:  David L Perez; Nassim Matin; Benjamin Williams; Kaloyan Tanev; Nikos Makris; W Curt LaFrance; Bradford C Dickerson
Journal:  Hum Brain Mapp       Date:  2017-10-28       Impact factor: 5.038

2.  Individual differences in corticolimbic structural profiles linked to insecure attachment and coping styles in motor functional neurological disorders.

Authors:  Benjamin Williams; Rozita Jalilianhasanpour; Nassim Matin; Gregory L Fricchione; Jorge Sepulcre; Matcheri S Keshavan; W Curt LaFrance; Bradford C Dickerson; David L Perez
Journal:  J Psychiatr Res       Date:  2018-04-06       Impact factor: 4.791

3.  Triggers and Clinical Presentations of Functional Neurological Disorders: Lessons from World War 1.

Authors:  Stefanie Caroline Linden
Journal:  Eur Neurol       Date:  2020-05-26       Impact factor: 1.710

4.  Resilience linked to personality dimensions, alexithymia and affective symptoms in motor functional neurological disorders.

Authors:  Rozita Jalilianhasanpour; Benjamin Williams; Isabelle Gilman; Matthew J Burke; Sean Glass; Gregory L Fricchione; Matcheri S Keshavan; W Curt LaFrance; David L Perez
Journal:  J Psychosom Res       Date:  2018-02-13       Impact factor: 3.006

5.  Gender Differences in Emotional Connotative Meaning of Words Measured by Osgood's Semantic Differential Techniques in Young Adults.

Authors:  Robert M Chapman; Margaret N Gardner; Megan Lyons
Journal:  Humanit Soc Sci Commun       Date:  2022-04-06

6.  Functional dystonia: A case-control study and risk prediction algorithm.

Authors:  Christopher D Stephen; David L Perez; Lori B Chibnik; Nutan Sharma
Journal:  Ann Clin Transl Neurol       Date:  2021-03-16       Impact factor: 4.511

Review 7.  Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda.

Authors:  David L Perez; Timothy R Nicholson; Ali A Asadi-Pooya; Indrit Bègue; Matthew Butler; Alan J Carson; Anthony S David; Quinton Deeley; Ibai Diez; Mark J Edwards; Alberto J Espay; Jeannette M Gelauff; Mark Hallett; Silvina G Horovitz; Johannes Jungilligens; Richard A A Kanaan; Marina A J Tijssen; Kasia Kozlowska; Kathrin LaFaver; W Curt LaFrance; Sarah C Lidstone; Ramesh S Marapin; Carine W Maurer; Mandana Modirrousta; Antje A T S Reinders; Petr Sojka; Jeffrey P Staab; Jon Stone; Jerzy P Szaflarski; Selma Aybek
Journal:  Neuroimage Clin       Date:  2021-03-11       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.